Omada Health (OMDA) Q2 FY26 Earnings Call

Record growth and profitability continued, but management expects second-half growth and EBITDA margins to moderate.

Q2 FY26 results, source: company transcript and SEC filings
QuarterQ2 FY26
Call date2026-08-06
Length50 minutes
EPS$0.08
Revenue$87.8M

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

Other quarters: Q4 FY25

All OMDA earnings ยท Back to OMDA overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.